Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto J Montero

Showing results (21-30 of 132) with videos related to

Pageof 14
Sort By:
JCO Oncology Practice|October 12, 2021
CDK 4/6 Inhibitors: Evolution and Revolution in the Management of ER+ Metastatic Breast CancerPriyanka M Reddy, James M Martin, Alberto J Montero
Cancer Biology & Therapy|July 6, 2007
Fatal rhabdomyolysis as a complication of ET-743 (Yondelis) chemotherapy for sarcomaAmy Skorupa, Matthew Beldner, Andrew Kraft, et al.
Journal of Medical Case Reports|December 4, 2012
Pneumonitis and pulmonary fibrosis in a patient receiving adjuvant docetaxel and cyclophosphamide for stage 3 breast cancer: a case report and literature reviewRoberto Ochoa, Pablo A Bejarano, Stefan Glück, et al.
Journal of Thrombosis and Haemostasis : JTH|September 4, 2019
Venous thromboembolism in breast cancer patients receiving cyclin-dependent kinase inhibitorsLorenzo Gervaso, Alberto J Montero, Xuefei Jia, et al.
Cancer|June 7, 2022
Reply to "Select cases might get a benefit from chemotherapy for Stage I pT1aN0M0 HER2+ breast cancer"Lifen Cao, Nickolas Stabellini, Amanda L Amin, et al.
Annals of Surgical Oncology|August 18, 2021
ASO Author Reflections: Decisions, Decisions: Neoadjuvant Chemotherapy, Neoadjuvant Endocrine Therapy, or Primary Surgery?Lifen Cao, Alberto J Montero, Robert Shenk, et al.
Breast Cancer Research and Treatment|April 2, 2013
A meta-analysis of anastrozole in combination with fulvestrant in the first line treatment of hormone receptor positive advanced breast cancerPui San Tan, Benjamin Haaland, Alberto J Montero, et al.
International Journal of Hematology|November 22, 2005
Acute respiratory distress syndrome after rituximab infusionAlberto J Montero, John J McCarthy, George Chen, et al.
Breast Cancer Research and Treatment|April 21, 2015
A review of systematic reviews of the cost-effectiveness of hormone therapy, chemotherapy, and targeted therapy for breast cancerVakaramoko Diaby, Rima Tawk, Vassiki Sanogo, et al.
Pharmacoeconomics - Open|February 23, 2018
Longitudinal Effects of Adjuvant Endocrine Therapy on the Quality of Life of Post-menopausal Women with Non-metastatic ER+ Breast Cancer: A Systematic ReviewHong Xiao, Xinyi Jiang, Cheng Chen, et al.
Pageof 14

Showing results (21-30 of 132) with videos related to

Sort By:
Pageof 14
JCO Oncology Practice|October 12, 2021
CDK 4/6 Inhibitors: Evolution and Revolution in the Management of ER+ Metastatic Breast CancerPriyanka M Reddy, James M Martin, Alberto J Montero
Cancer Biology & Therapy|July 6, 2007
Fatal rhabdomyolysis as a complication of ET-743 (Yondelis) chemotherapy for sarcomaAmy Skorupa, Matthew Beldner, Andrew Kraft, et al.
Journal of Medical Case Reports|December 4, 2012
Pneumonitis and pulmonary fibrosis in a patient receiving adjuvant docetaxel and cyclophosphamide for stage 3 breast cancer: a case report and literature reviewRoberto Ochoa, Pablo A Bejarano, Stefan Glück, et al.
Journal of Thrombosis and Haemostasis : JTH|September 4, 2019
Venous thromboembolism in breast cancer patients receiving cyclin-dependent kinase inhibitorsLorenzo Gervaso, Alberto J Montero, Xuefei Jia, et al.
Cancer|June 7, 2022
Reply to "Select cases might get a benefit from chemotherapy for Stage I pT1aN0M0 HER2+ breast cancer"Lifen Cao, Nickolas Stabellini, Amanda L Amin, et al.
Annals of Surgical Oncology|August 18, 2021
ASO Author Reflections: Decisions, Decisions: Neoadjuvant Chemotherapy, Neoadjuvant Endocrine Therapy, or Primary Surgery?Lifen Cao, Alberto J Montero, Robert Shenk, et al.
Breast Cancer Research and Treatment|April 2, 2013
A meta-analysis of anastrozole in combination with fulvestrant in the first line treatment of hormone receptor positive advanced breast cancerPui San Tan, Benjamin Haaland, Alberto J Montero, et al.
International Journal of Hematology|November 22, 2005
Acute respiratory distress syndrome after rituximab infusionAlberto J Montero, John J McCarthy, George Chen, et al.
Breast Cancer Research and Treatment|April 21, 2015
A review of systematic reviews of the cost-effectiveness of hormone therapy, chemotherapy, and targeted therapy for breast cancerVakaramoko Diaby, Rima Tawk, Vassiki Sanogo, et al.
Pharmacoeconomics - Open|February 23, 2018
Longitudinal Effects of Adjuvant Endocrine Therapy on the Quality of Life of Post-menopausal Women with Non-metastatic ER+ Breast Cancer: A Systematic ReviewHong Xiao, Xinyi Jiang, Cheng Chen, et al.
Pageof 14